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Structural Investigation of the Acidosis Resistant Cardiac Troponin I
Mutant A162H
Sandra E. Pineda-Sanabria, Ian M. Robertson, Monica X. Li,
Brian D. Sykes.
University of Alberta, Edmonton, AB, Canada.
Cardiac muscle contraction is regulated by troponin in a Ca2þ-dependent man-
ner. After Ca2þ binds to the N-domain of troponin C (cNTnC), the switch re-
gion of troponin I (cTnI) associates with cNTnC stabilizing an open
conformation that favors contraction. During myocardial ischemia, heart mus-
cle becomes acidic (pH ~6.2) reducing calcium sensitivity and ATPase activity.
The acidosis-resistant neonatal TnI isoform contains a histidine residue (H130)
that is replaced by an alanine in adult TnI; substitution of this alanine with his-
tidine restores calcium sensitivity and ATPase activity in vitro and enhances
myocardial contractility in vivo (Dargis (2002) JBC; Day (2006) Nature Med-
icine). However, the effect of this substitution on the switch peptide affinity and
mode of interaction with cNTnC is unknown. We used NMR spectroscopy to
investigate the binding of an extended switch region of cTnI (residues 144-
170), containing the A162H substitution (analog of H130 in skeletal), to
cNTnC to assess binding under normal and acidic conditions. We found that
the histidine enhances the switch peptide affinity for cNTnC by a factor of
~5 at pH 7 and by more than 40 fold at pH 6. We also investigated whether elec-
trostatics are responsible for the apparent enhancement in binding by determin-
ing the pKa of this histidine and glutamate residues on cNTnC, since deviation
from normal values indicates an electrostatic interaction. We found that gluta-
mate residues E15 and E19 in cNTnC show a biphasic titration curve when
A162H cTnI is bound, with the first pKa corresponding to glutamate ionization
and the second is associated with H162. In conclusion, cTnI A162H improves
myocardial performance during acidosis by making electrostatic interactions
with E15 and E19 on cNTnC, increasing the binding affinity of the switch pep-
tide and promoting the open state of cNTnC.
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Transgenic Mice with a Low Expression Rate of the FHC LinkedMutation
cTnI-DK184 Exhibit Predominantly Signs of Diastolic Dysfunction
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Sarah Moellendorf2, Axel Go¨decke2, Robert Stehle1, Gabriele Pfitzer1.
1University of Cologne, Koeln, Germany, 2University of Duesseldorf,
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Point mutations in genes coding for cardiac troponin-I (cTnI) were linked to
familial hypertrophic cardiomyopathy (FHC). We have shown that cardiac
myofibrils isolated from a transgenic mouse model carrying the FHC-linked
mutation cTnI-DK184 in which >90% of cTnI (h-TG) is mutated have an in-
crease in Ca2þ-sensitivity and in passive force, and a slower rate of relaxation
(Iorga et al., 2008). In patients the mutated protein amounts to typically<50%.
Therefore, we investigated how myofibrillar function is affected in a mouse
model in which only ~10% of cTnI (l-TG) carries the mutation. In skinned fi-
bers from the l-TG mice, Ca2þ-sensitivity was similar in WT and TG mice at
110% of slack length. After pre-stretching the fibers to 125% of slack length,
Ca2þ-sensitivity in TG fibers was higher compared to WT (pCa50 5.32 in
WT and 5.49 in l-TG, p<0.01). In contrast, the increase in passive force and
the slow down of the rate of relaxation was present not only in myofibrils
from h-TG but also from l-TG mice. In line with these findings, tip catheter
measurements showed an increase in end diastolic pressure in both h-TG and
l-TG mice in vivo. Taken together our results demonstrate that even with
a very low expression rate of the FHC-linked mutation, cTnI-DK184 signs of
diastolic dysfunction both at the myofibrillar and organ level can be detected.
The effects of the mutation on the systolic function in contrast appear to depend
on the expression level of the mutant protein. This dose dependency may thus
underlie at least in part the variable gene-phenotype relation.
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Cardiac Troponin I C-Terminal Mutations (K178E and K179E) Cause
Severe Heart Failure and Early Mortality in Transgenic Mice
Pierre-Yves Jean-Charles, Yuejin Li, Changlong Nan, Nariman Gobara,
Xupei Huang.
Florida Atlantic University, Boca Raton, FL, USA.
The C-terminal region of cardiac troponin I (cTnI164-210) plays an important
role in cardiac muscle contraction. Most genetic cardiomyopathies in human
are associated with the mutations in cTnI C-terminus. Among them, K178E
mutation was reported to cause restrictive cardiomyopathy (RCM) in human.
Deletion of K177 is related to hypertrophic cardiomyopathy (HCM). Since
the amino acids numbered 173-181 bind to actin, which increases the inhibitory
effect of TnI, we hypothesize that K177 and K178 are both critical for normal
cardiac function. We modeled the RCM mutation of lysine 178/glutamate(K178E) in human cTnI by cardiac specific expression of the mutated protein
(cTnI179Glu in mouse sequence) in transgenic mice. In addition, we created
cTnI178Glu transgenic mice expressing cTnI K178E as a comparison. The
RCM cTnI179Glu transgenic mice showed a dramatic phenotype of a high rate
of early death. Some survived TG mice were infertile. Interestingly, the muta-
tion of cTnI K178E (cTnI K177E in human sequence) had a similar phenotype
as shown in RCM cTnI179Glu mice. The replacement of the mutant cTnI K178E
in cTnI178Glu mouse lines was about 20-40%. Bi-atrial enlargement was a dra-
matic sign observed in most of the cTnI178Glu TG mice, and was developed
early at age of 2 weeks. Severe cardiac dysfunction and early death were ob-
served in these TG mice as well. The data from transgenic mouse studies indi-
cate that like RCM cTnI K179E mutation, the cTnI K178E mutation in mouse
hearts can also cause severe cardiomyopathy with heart failure and early death,
suggesting that cTnI C-terminus is critical in maintaining normal cardiac
function.
(Supported by NIH GM073621 and AHA09GRNT2400138)
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Dilated cardiomoypathy (DCM) is a disease characterized by decreased con-
tractility and enlargement of cardiac chambers. We have previously shown
that E54K mutation in a-tropomyosin (TM54) reduces myofilament Caþ2 sen-
sitivity and causes DCM. Thus, we hypothesized that sensitization of the myo-
filament to Caþ2 in early phase of DCM would rescue the phenotype of the
disease. Four groups were generated: non-transgenic (NTG), TM54,slow skel-
etal troponin I (ssTnI) and TM54/ssTnI. To sensitize TM54 myofilament we
crossbred TM54 mice with ssTnI expressing mice, which increased Caþ2 sen-
sitivity based on force pCa measurements. The systolic function was signifi-
cantly reduced in the TM54 mice compared to NTG, but restored in TM54/
ssTnI mice. TM54 mice also showed increased diastolic LV dimension and
HW/BW ratios when compared to NTG, which were improved in the TM54/
ssTnI group. Phosphorylation levels of ERK 1/2 trended toward a decrease
in TM54 compared to ssTnI control and was restored in the TM54/ssTnI group.
b-myosin heavy chain expression was increased in the TM54 animals com-
pared to NTG. When the TM54 animals were crossed with ssTnI, the expres-
sion of b-myosin heavy chain significantly decreased thereby partially
restoring normal isoform distribution. Analysis by 2D-DIGE indicated a signif-
icant decrease in two phosphorylated spots of troponin I in the TM54/ssTnI an-
imals compared to NTG and TM54. The decrease in troponin I phosphorylation
contributes to the increased Caþ2 sensitivity in the ssTnI transgenic crossed
with TM54 transgenic animals. Analysis by 2D-DIGE also indicated no signif-
icant changes in troponin T, regulatory light chain, myosin binding protein C
and tropomyosin phosphorylation. Our data indicate that myofilament sensiti-
zation to Caþ2 may be a useful preventative therapeutic strategy in
sarcomere-linked DCM associated with decreased sensitivity.
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Molecular Mechanisms of A164H cTnI
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Troponin I (TnI) has a central, isoform-dependent role in ischemic contractile
failure. The fetal heart expresses the slow skeletal TnI (ssTnI) isoform which
confers protection from ischemia-mediated contractile failure relative to the
adult expressed cardiac TnI (cTnI) isoform. A single codon substitution in
cTnI, A164H, reverts significantly to an ssTnI phenotype, in specifics, confer-
ring protection from ischemia-mediated contractile failure. Importantly, unlike
ssTnI, cTnI A164H does not alter contractile performance under baseline con-
ditions. The molecular mechanisms for the marked enhancement in myocyte
function under pathophysiological conditions with no detected effects under
baseline conditions have yet to be determined. Isoform specific residues in he-
lix 4 of TnI were investigated through structure/function analysis to gain insight
into this mechanism. Molecular dynamics simulation for cTnI, Q157R/A164H/
E166V/H173N cTnI (QAEH), A164H cTnI, and ssTnI in complex with cTnC,
showed that substitution of cTnI with the ssTnI residues alters the intermolec-
ular interactions between TnI and cTnC. These findings suggest that these res-
idues are important for the conformation of helix 4 in regards to cTnC. To
investigate if these substitutions alter function, adult cardiac myocytes were
transduced with adenovirus expressing QAEH cTnI and sarcomere dynamics
were analyzed. QAEH cTnI showed a similar phenotype to ssTnI, increasing
